Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-010528
Filing Date
2024-08-01
Accepted
2024-08-01 07:43:22
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20240630x10q.htm   iXBRL 10-Q 2210878
2 EX-10.1 qure-20240630xex10d1.htm EX-10.1 893240
3 EX-10.2 qure-20240630xex10d2.htm EX-10.2 95573
4 EX-10.3 qure-20240630xex10d3.htm EX-10.3 179571
5 EX-10.4 qure-20240630xex10d4.htm EX-10.4 115394
6 EX-10.5 qure-20240630xex10d5.htm EX-10.5 30507
7 EX-31.1 qure-20240630xex31d1.htm EX-31.1 15052
8 EX-31.2 qure-20240630xex31d2.htm EX-31.2 15061
9 EX-32.1 qure-20240630xex32d1.htm EX-32.1 14744
  Complete submission text file 0001558370-24-010528.txt   9566535

Data Files

Seq Description Document Type Size
10 EX-101.SCH qure-20240630.xsd EX-101.SCH 50820
11 EX-101.CAL qure-20240630_cal.xml EX-101.CAL 56753
12 EX-101.DEF qure-20240630_def.xml EX-101.DEF 274239
13 EX-101.LAB qure-20240630_lab.xml EX-101.LAB 472240
14 EX-101.PRE qure-20240630_pre.xml EX-101.PRE 387484
75 EXTRACTED XBRL INSTANCE DOCUMENT qure-20240630x10q_htm.xml XML 1240559
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 241164319
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)